NIRVANA-1: Maintenance therapy with niraparib versus niraparib –bevacizumab in patients with advanced ovarian cancer - supplementary material
收藏Taylor & Francis Group2024-05-15 更新2026-04-16 收录
下载链接：
https://tandf.figshare.com/articles/dataset/NIRVANA-1_Maintenance_therapy_with_niraparib_versus_niraparib_bevacizumab_in_patients_with_advanced_ovarian_cancer_-_supplementary_material/24065433
下载链接
链接失效反馈官方服务：
资源简介：
<b>Criteria for discontinuing allocated interventions for participant and dose modifications</b>
提供机构：
Freyer, Gilles; Cheol Lim, Myong; Corbaux, Pauline; Ray-Coquard, Isabelle; Van Nieuwenhuysen, Els; Raspagliesi, Francesco; Hasegawa, Kosei; Gonzalez, Antonio; Sghaier, Syrine
创建时间：
2023-08-31
